1. Fink, J.K., Hereditary spastic paraplegia: clinicopathologic features and emerging molecular mechanisms, Acta Neuropathol., 2013, vol. 126, no. 3, pp. 307–328. doi 10.1007/s00401-013-1115-8
2. Hazan, J., Fonknechten, N., Mavel, D., et al., Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia, Nat. Genet., 1999, vol. 23, no. 3, pp. 296–303.
3. Magzhanov, R.V., Saifullina, E.V., Idrisova, R.F., et al., Epidemiological characteristics of hereditary spastic paraplegia in the Republic of Bashkortostan, Med. Genet., 2013, vol. 12, no. 7, pp. 12–16.
4. Lumb, J.H., Connell, J.W., Allison, R., and Reid, E., The AAA ATPase spastin links microtubule severing to membrane modelling, Biochim. Biophys. Acta, Mol. Cell Res., 2012, vol. 1823, no. 1, pp. 192–197. doi 10.1016/jbbamcr.2011.08.010
5. Fonknechten, N., Mavel, D., Byrne, B., et al., Spectrum of SPG 4 mutations in autosomal dominant spastic paraplegia, Hum. Mol. Genet., 2000, vol. 9, no. 4, pp. 637–644.